Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Pipeline (Phase 3 trials completed, FDA decision pending as of April 2026): Survodutide (BI 456906): Dual GLP-1/glucagon agonist from Boehringer Ingelheim
Obese patients are more likely to see knee arthritis due to stress on the joints caused by their weight, which leads to cartilage breakdown and inflammation
Husain M, Bain SC, Jeppesen OK, Lingvay I, Srrig R, Treppendahl MB, et al
Key Takeaways at a Glance Bottom line: GLP-1 is a gutbrain hormone that helps regulate appetite, blood sugar and digestion, and it responds strongly to your diet, movement, sleep and gut healthnot just genetics or medications
Thats how were looking into the future.
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
